Longevity Health Holdings Announces Major Rebranding Effort
Longevity Health Holdings, formerly known as Carmell Corporation, has embarked on a significant corporate transformation aimed at aligning its identity more closely with its evolving business strategies. The company, which specializes in bio-aesthetics, seeks to establish a stronger market presence and resonate with investors through this rebranding initiative.
New Name, New Trading Symbols
As part of this strategic rebranding, the company will operate under its new corporate name, Longevity Health Holdings, Inc. Effective immediately, the company's common stock and redeemable warrants will trade under the symbols “XAGE” and “XAGEW”. This signals a fresh start and positions the company for future growth opportunities while maintaining its existing product branding.
Emphasizing a Focus on Longevity and Healthy Aging
Rajiv Shukla, the Chairman & CEO, believes that the new name better encapsulates their commitment to longevity and healthy aging. This rebranding not only reflects their current business activities but also paves the way for potential expansions into new fields such as diagnostics and nutrition. The company aims to leverage both acquisitions and strategic partnerships along with organic growth to enhance its market position.
Innovative Product Pipeline and Recent Acquisition
The recent acquisition of Elevai Skincare, Inc., completed in January this year, has significantly broadened the company's product offerings by integrating their innovative stem cell exosome technology into Longevity Health Holdings' existing product portfolio. This advancement merges cutting-edge science with practical application in consumer products.
Sales Growth Amid Strategic Changes
Following the acquisition, the company reported substantial sales growth, averaging 34% in the first two months of 2025 compared to the same period a year prior. This robust increase came even as the company strategically invested in expanding its salesforce while reducing Elevai's operational burn rate by over 50% through cost-cutting measures.
Anticipated Revenue and Future Product Launches
Looking forward, Longevity Health Holdings forecasts revenue between $3 to $4 million for the fiscal year from its current lineup of products, excluding any new product launches or additional partnerships. This optimistic forecast underscores the company's commitment to innovation and market expansion.
Upcoming Product Launches for Q2 2025
The company is preparing to debut an exciting array of new products in the upcoming quarter, including:
- Hair Growth Serum
- Soapless Facial Cleanser
- Undereye Crème
- VSA Toning Moisturizer (for visible skin areas such as the neck and arms)
Leadership Enhancements and Continued Commitment
In conjunction with the rebranding, Longevity Health Holdings also announced the appointment of Patrick Sturgeon as the new Vice Chairman. With his extensive experience as a founding team member and his contributions as CFO since 2021, Mr. Sturgeon is poised to play a pivotal role in leading the company into its next chapter of growth.
Frequently Asked Questions
What prompted the rebranding to Longevity Health Holdings?
The rebranding initiative was aimed at better aligning the company's identity with its focus on longevity and healthy aging, reflecting its commitment to innovation in this sector.
What new products are expected from Longevity Health Holdings?
The company plans to launch several new products, including a Hair Growth Serum, Soapless Facial Cleanser, Undereye Crème, and a VSA Toning Moisturizer.
What is the expected revenue for the upcoming fiscal year?
Longevity Health Holdings anticipates revenues between $3 to $4 million, based on its current product offerings.
Who has been appointed as Vice Chairman?
Patrick Sturgeon has been appointed as Vice Chairman, enhancing the leadership team with his extensive background in the company since its inception.
How does the company plan to grow?
The company's growth strategy includes acquisitions, strategic partnerships, and expanding its existing product line to capture new market opportunities.
